| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/06/2010 | US7749486 LOX-GFP marker and methods of analyzing tumor burden in ascites or in lung; quantitative tumor burden assessment and improved efficacy evaluation; injecting an athymic mouse intravenously with GFP-expressing tumor cells; fast drug-screening; accuracy; antimetastasic, -tumor, and -carcinogenic agents |
| 07/06/2010 | US7749485 Liposomal assembly for therapeutic and/or diagnostic use |
| 07/01/2010 | WO2010074326A1 Probe for a biological specimen and labelling method and screening method using the probe |
| 07/01/2010 | WO2010074325A1 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method |
| 07/01/2010 | WO2010073126A2 Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof |
| 07/01/2010 | WO2010072752A2 Fluorescent probes |
| 07/01/2010 | US20100169994 Animal model |
| 07/01/2010 | US20100169993 Ligand-regulable transactivation systems, methods of use thereof, methods of detecting estrogen receptor ligands, and methods of differentiating estrogen receptor ligand agonists and antagonists |
| 07/01/2010 | US20100169987 Animal model simulating neurologic disease |
| 07/01/2010 | US20100169985 Transgenic Mouse Models for Diseases Caused by mtDNA Mutations and Related Methods |
| 07/01/2010 | US20100168554 Evaluating Cardiac Function With Dynamic Imaging Techniques and Contrast Media |
| 07/01/2010 | US20100167936 Use of ascorbic acid derivatives for the functionalization of matrices |
| 07/01/2010 | US20100166669 Methods of imaging inflammation in pancreatic islets |
| 07/01/2010 | US20100166668 Ct negative contrast medium of aqueous matrix for digestive tract and the preparation method thereof |
| 07/01/2010 | US20100166667 Magnetic resonance imaging |
| 07/01/2010 | US20100166666 Nanoparticle contrast agents for diagnostic imaging |
| 07/01/2010 | US20100166665 Nanoparticle contrast agents for diagnostic imaging |
| 07/01/2010 | US20100166664 Nanoparticle contrast agents for diagnostic imaging |
| 07/01/2010 | US20100166663 Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell |
| 07/01/2010 | US20100166662 Magnetic resonance imaging method using vanadyl-based contrast agents |
| 07/01/2010 | US20100166661 siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION |
| 07/01/2010 | US20100166660 Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine |
| 07/01/2010 | US20100166659 Use of cyanine dyes for the diagnosis of proliferative diseases |
| 07/01/2010 | US20100166658 Monkey homolog of human oncostatin m |
| 07/01/2010 | US20100166657 USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER |
| 07/01/2010 | US20100166656 Diagnostic And Radiotherapeutic Contrast Agents And Process For Their Preparation |
| 07/01/2010 | US20100166655 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 07/01/2010 | US20100166654 Single-Drug Multi-Ligand Conjugates for Targeted Drug Delivery |
| 07/01/2010 | US20100166652 Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody |
| 07/01/2010 | US20100166650 Molecular imaging of living subjects using raman spectroscopy and labeled raman nanoparticles |
| 06/30/2010 | EP2201897A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 06/30/2010 | EP2200971A1 Contrast agents |
| 06/30/2010 | EP2200670A2 Bone substitute containing a contrast agent, method for preparing same and uses thereof |
| 06/30/2010 | EP2200656A1 Contrast agents |
| 06/30/2010 | EP2200655A1 Contrast agents |
| 06/30/2010 | EP2200654A2 Diagnostic substances for optical imaging testing on the basis of nanoparticular formulations |
| 06/30/2010 | EP1284727B1 Intracorporeal medicaments for photodynamic treatment of disease |
| 06/30/2010 | CN101765562A Process for production of surface-coated inorganic particles |
| 06/30/2010 | CN101759804A Anti-human thyroglobulin monoclonal antibody and application thereof |
| 06/30/2010 | CN101757643A Emulsion based on stabilizing agent, preparation method and application thereof |
| 06/30/2010 | CN101757642A Method for preparing gadolinium-containing nano particles |
| 06/30/2010 | CN101322848B Composition for gastroscopy and preparation thereof |
| 06/29/2010 | US7747309 Method and apparatus for administration of contrast agents for use in magnetic resonance arteriography |
| 06/29/2010 | US7747304 Arrangement and method for the spatially resolved determination of state variables in an examination area |
| 06/29/2010 | US7745569 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques |
| 06/29/2010 | US7745214 for assessing the effect of candidate chemotherapeutic drugs on the growth of brain tumors; fibroblast growth factor expressing cells and diagnosis and treatment of tumors; antiproliferative agents |
| 06/29/2010 | US7745155 In-vivo monitoring of circulating apoptotic cells |
| 06/29/2010 | US7744907 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 06/29/2010 | US7744880 cell proliferation-inhibiting activity by ADCC (antibody-dependent cell-mediated cytotoxicity) activity and CDC (complement-dependent cytotoxicity); hepatic cancer |
| 06/29/2010 | US7744854 Optimizing the regimen for administering anticarcinogenic and -tumor agents by administering methylselenocysteine and/or seleno-L-methionine which 'normalize' the existing vessels for better drug delivery; monitoring and upon detection of vessel maturation, administering a drug dose |
| 06/29/2010 | US7744852 Device for marking a cavity in a breast for subsequent visualization including a delivery opening, first and second markers movable through opening, visualized by ultrasound and radiopacity; percutaneous minimally invasive large intact tissue sample collection; inserts; positioning; |
| 06/29/2010 | US7744851 Rreacting a hydrated 18F-radiolabeled fluoride ion source with an unsaturated carrier compound in a nucleophilic reaction to produce an 18F-radiolabeled carrier compound and reacting the 18F-radiolabeled carrier compound with a nucleophilic composition in a second nucleophilic reaction; tomography |
| 06/29/2010 | CA2404737C Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug |
| 06/29/2010 | CA2358439C Metastasis models using green fluorescent protein (gfp) as a marker |
| 06/29/2010 | CA2134030C Soluble interferon .alpha.-receptor, its preparation and use |
| 06/24/2010 | WO2010071293A2 Target indicator for radiological treatment |
| 06/24/2010 | WO2010070620A1 Erythrocyte-based delivery system, method of preparation and uses thereof |
| 06/24/2010 | WO2010070126A2 Smart contrast agents for mri imaging |
| 06/24/2010 | WO2010039799A9 X-ray and/or metal detectable articles and method of making the same |
| 06/24/2010 | WO2010038044A3 Imaging techniques using a tridentate ligand |
| 06/24/2010 | WO2010028156A3 Dual modality detection of apoptosis |
| 06/24/2010 | WO2010021519A3 T1-t2 dual modal mri contrast agents |
| 06/24/2010 | WO2010018216A3 Fluorescent emulsion of indocyanine green |
| 06/24/2010 | WO2008152490A3 Loaded target-specific vesicles, method of producing the vesicles and their use in medical imaging |
| 06/24/2010 | US20100162416 Multi-stage stem cell carcinogenesis |
| 06/24/2010 | US20100162415 Transgenic mice expressing humanized vegf |
| 06/24/2010 | US20100158910 Treatment of renal cell carcinoma with anti-cd70 antibody-drug conjugates |
| 06/24/2010 | US20100158817 T1 mri trackable drug delivery particles, uses and methods thereof |
| 06/24/2010 | US20100158813 Microbubbles as drug delivery device |
| 06/24/2010 | US20100158812 Anti-Cancer Medicine Both for Diagnosing and Treating Cancer |
| 06/24/2010 | US20100158811 Assessing brain aneurysms |
| 06/24/2010 | US20100158810 Enhanced 13C NMR By Thermal Mixing With Hyperpolarized 129XE |
| 06/24/2010 | US20100158809 Truncated pap2 and methods of making and using same |
| 06/24/2010 | US20100158808 Altered Activity of Toll-Like Receptors |
| 06/24/2010 | US20100158807 Receptor |
| 06/24/2010 | US20100158806 Compositions for Delivery of Therapeutics and Other Materials |
| 06/24/2010 | US20100158805 Quantum dot labeled stem cells for use in cardiac repair |
| 06/24/2010 | US20100158804 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled esters and acids by sensitized photo-induced free radical carbonylation |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/24/2010 | US20100158796 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
| 06/24/2010 | CA2747721A1 Tfpi inhibitors and methods of use |
| 06/24/2010 | CA2744298A1 Smart contrast agents for mri imaging |
| 06/23/2010 | EP2198922A1 CNS chloride modulation and uses thereof |
| 06/23/2010 | EP2198854A2 Sustained-release liposomal anesthetic compositions |
| 06/23/2010 | EP2197902A1 Method for the recombinant production of magnetic nanoparticles |
| 06/23/2010 | EP2197498A2 Clustered magnetic particles as tracers for magnetic particle imaging |
| 06/23/2010 | EP1613348B1 Methods for modulating angiogenesis with apelin compositions |
| 06/23/2010 | CN101748121A Protein small ubiquitin-like modifier (SUMO) deletion form organism zebra fish model and establishing method thereof |
| 06/23/2010 | CN101748098A Breast cancer transplantable tumor spontaneous metastasis model and application thereof |
| 06/23/2010 | CN101745126A Method for preparing water soluble medicament-entrapping ultrasound contrast agent |
| 06/23/2010 | CN101745125A Dual-function chitosan particle and preparation method thereof |
| 06/23/2010 | CN101745124A Gadolinium-containing silicon dioxide nanosphere magnetic resonance contrast agent and preparation method thereof |
| 06/22/2010 | US7741436 Injecting the tripeptide, Lys-Asp-Ile, derived from the neurite outgrowth-promoting domain of laminin-1, into the epidural space of the spine to regenerate the tissue |
| 06/22/2010 | US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders |
| 06/22/2010 | US7740867 Using insertional mutation as tool in detecting mycobaterial genes associated with infectivity; transposon mediated gene disruption |
| 06/22/2010 | US7740854 Treatment of macrophage mediated disease |
| 06/22/2010 | US7740845 Reducing tumor cells; isolated nucleic acids, proteins, peptides, cells, vectors, liposomes, antibodies, transgenic animals; drug screening; imaging, diagnosis |
| 06/22/2010 | US7740830 Imaging, diagnosis and treatment of disease |
| 06/22/2010 | CA2389553C Heteroaryl-diazabicycloalkanes |
| 06/17/2010 | WO2010068705A2 Encapsulated agent guided imaging and therapies |